We are live on ! Find out more
ZCA

Zeke Capital Advisors Portfolio holdings

AUM $1.53B
1-Year Est. Return 17.37%
This Fund
S&P 500
This Quarter Est. Return
-17.6%
1 Year Est. Return
-17.37%
3 Year Est. Return
+41%
5 Year Est. Return
+67.71%
10 Year Est. Return
AUM
$1.5B
AUM Growth
-$477M
Cap. Flow
-$88.5M
Cap. Flow %
-5.88%
Top 10 Hldgs %
46.81%
Holding
547
New
33
Increased
150
Reduced
166
Closed
64

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 25.02%
2 Communication Services 12.99%
3 Technology 11.89%
4 Real Estate 9.82%
5 Financials 7.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SEER icon
451
Seer Inc
SEER
$121M
$166K 0.01%
18,505
+6,168
+50% +$56.4K
ING icon
452
ING
ING
$102B
$146K 0.01%
14,724
-1,229
-8% -$12.6K
BRKL
453
DELISTED
Brookline Bancorp
BRKL
$136K 0.01%
10,248
BCTXW
454
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$117K 0.01%
45,000
MRC
455
DELISTED
MRC Global
MRC
$117K 0.01%
11,719
VISN
456
Vistance Networks Inc
VISN
$2.28B
$111K 0.01%
18,066
MNKD icon
457
MannKind Corp
MNKD
$1.24B
$111K 0.01%
29,220
PLTR icon
458
Palantir
PLTR
$375B
$91K 0.01%
10,000
-610
-6% -$6.03K
OWLT.WS
459
DELISTED
Owlet, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
OWLT.WS
$85K 0.01%
300,000
FSP
460
Franklin Street Properties
FSP
$47.1M
$81K 0.01%
19,433
ALTUW
461
DELISTED
Altitude Acquisition Corp Warrant
ALTUW
$78K 0.01%
625,000
SRG
462
Seritage Growth Properties
SRG
$136M
$77K 0.01%
14,835
TTI icon
463
TETRA Technologies
TTI
$1.27B
$77K 0.01%
18,962
-3,920
-17% -$17.3K
IKT icon
464
Inhibikase Therapeutics
IKT
$378M
$70K ﹤0.01%
15,633
DBRG icon
465
DigitalBridge
DBRG
$2.95B
$62K ﹤0.01%
3,190
-44
-1% -$1.07K
HUYA
466
Huya Inc
HUYA
$554M
$58K ﹤0.01%
15,000
ZYNE
467
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$57K ﹤0.01%
49,700
BLND icon
468
Blend Labs
BLND
$472M
$54K ﹤0.01%
+22,880
New +$85.5K
VEEE icon
469
Twin Vee PowerCats
VEEE
$5.25M
$54K ﹤0.01%
54
FLNT
470
Fluent
FLNT
$114M
$52K ﹤0.01%
7,285
STEX
471
Streamex Corp
STEX
$75.3M
$47K ﹤0.01%
7,087
-8,537
-55% -$80.2K
ENDP
472
DELISTED
Endo International plc
ENDP
$47K ﹤0.01%
100,000
KRBP
473
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
$45K ﹤0.01%
3,567
FATBW
474
DELISTED
FAT Brands Inc. Warrant
FATBW
$36K ﹤0.01%
10,000
PMVC.WS
475
DELISTED
PMV Consumer Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
PMVC.WS
$22K ﹤0.01%
200,000

Similar funds

Zeke Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Zeke Capital Advisors held 547 positions worth $1.5B, down 24% from $1.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Zeke Capital Advisors withdrew a net $88.5M in Q2 2022, closing 64 positions and reducing 166 holdings. Its most notable exit was MGM Growth Properties LLC Class A common shares representing limited liability company interests, an estimated $49.2M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 25% of assets, down from 31% a quarter earlier, followed by Communication Services and Technology.

Against the trend, Zeke Capital Advisors opened a new position in Vail Resorts worth $22.6M.

  • Zeke Capital Advisors's largest Q2 2022 buy was Vail Resorts: 103,760 shares worth $22.6M.
  • Zeke Capital Advisors added most to VICI Properties in Q2 2022, an estimated $51.3M increase.
  • Zeke Capital Advisors's biggest Q2 2022 reduction was Boyd Gaming, cutting an estimated $96.7M.
  • Zeke Capital Advisors fully exited MGM Growth Properties LLC Class A common shares representing limited liability company interests in Q2 2022, selling an estimated $49.2M.
  • Zeke Capital Advisors's ten largest holdings make up 47% of its $1.5B portfolio in Q2 2022.
  • Zeke Capital Advisors opened 33 new positions and closed 64 in Q2 2022.
  • Zeke Capital Advisors's portfolio value fell 24% quarter-over-quarter to $1.5B.

Based on Zeke Capital Advisors's 13F filing for Q2 2022, filed 9 Aug 2022.